Global Fetal Monitors Market - 2022-2029
The Global Fetal Monitors Market is expected to grow at a CAGR of 7.2% during the forecasting period (2022-2029).
A fetal monitor is a diagnostic tool that provides accurate vital information about the mother and fetus such as fetal heart rate, fetal movement pattern, and the overall fetal growth during pregnancy. It mainly monitors the well-being of the fetus and the progress of labor. In medical terms, it is referred to as a medical method to check the health of an unborn baby to ensure a safe birth. In addition, it is also used to monitor chronic lung diseases, mental retardation, neonatal diseases, hypothermia, vision & hearing problems, and jaundice.
The global fetal monitors market growth is driven by a rise in the prevalence of cardiopulmonary diseases, technological advancements such as non-invasive surgeries, an increase in government and non-government initiatives for maternal and fetal health across the world, rise in awareness and willingness to invest the in development of fetal monitoring.
Advanced and innovative fetal monitoring technologies will drive the market growth
The fetal monitoring market is expanding with the latest innovative technologies, backed by escalating research and product launches. Fetal monitoring technologies are now being streamlined to provide greater assistance in utero fetal surgeries, consisting of challenging physical fetal access and technological complications. Fetal cardiac assessments have also witnessed progress that supports high-fidelity hemodynamic and continuous physiologic monitoring, thus enabling early diagnosis and treatment. Computer-Aided Decision Support Systems and Artificial Intelligence (AI) are also utilized in continuous cardiotocography (CTG) or fetal heart rate (FHR) auscultation during labor. The patient’s electronic health records (EHRs) are utilized along with computational methods, machine learning, and deep learning tools. Research and technological advancements in fetal monitoring systems have increased the focus on noninvasive monitoring procedures. Obstetrics has been introduced with noninvasive diagnosis technologies such as Doppler studies, cell-free fetal DNA assessment, electronic fetal monitoring (EFM), and fetal acid-base status.
Fetal and neonatal assessments are carried out during antepartum via percutaneous umbilical cord blood sampling and during intrapartum with fetal scalp blood sampling immediately after birth. Fetal phonocardiography has been integrated with advanced data acquisition systems and databases. Progressing data analytics, synthetic data generation by advanced mathematical models, and classifications & processing algorithms are under active research & development to increase fetal motoring data processing efficacy.
The high cost associated with fetal monitoring equipment will hamper the growth of the market
The advanced Portabilityintegrated into fetal monitors comes at a heavy price. Sophisticated monitoring techniques such as Doppler ultrasound machines also incur hefty charges. The probes used in the Doppler Portability(for example, the Philips Doppler transducer) range from USD 4,500 to USD 17,000. The SonoScape system from GE Healthcare costs around USD 9,000. These machines also incur maintenance charges, which amount to 15% of the unit's purchasing cost. The high costs of fetal monitoring equipment can be challenging to low-income nations and low-resource hospitals, thus restraining this market's growth.
COVID-19 Impact Analysis
The coronavirus pandemic has compelled regulatory bodies, such as the FDA, to ease their regulatory norms for fetal monitors to support the uninterrupted care regime of expectant mothers. Relaxations in rules have paved the way for several key players to smoothly launch fetal monitors equipped with tele-ultrasound monitoring, noninvasive features, and portable technologies. For instance, the FDA released its updated April 2020 FDA guidance amid the pandemic, under which Philips successfully launched its fetal monitor, Avalon CL, in the US on June 12, 2020. The FDA’s enforcement policy for noninvasive fetal and maternal monitoring devices aims to increase access to devices that could reduce the need for in-clinic visits and reduce the burden on doctor’s offices and hospitals during the pandemic.
The electronic fetal monitoring system segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
Electronic fetal monitoring is commonly used to assess fetal well-being during labor. Although detection of fetal compromise is one benefit of fetal monitoring, there are also risks, including false-positive tests that may result in unnecessary surgical intervention. Since variable and inconsistent interpretation of fetal heart rate tracings may affect management, a systematic approach to interpreting the patterns is important. The fetal heart rate undergoes constant and minute adjustments in response to the fetal environment and stimuli. Fetal heart rate patterns are classified as reassuring, nonreassuring or ominous. Nonreassuring patterns such as fetal tachycardia, bradycardia and late decelerations with good short-term variability require intervention to rule out fetal acidosis. Ominous patterns require emergency intrauterine fetal resuscitation and immediate delivery. Differentiating between a reassuring and nonreassuring fetal heart rate pattern is the essence of accurate interpretation, which is essential to guide appropriate triage decisions.
North America region holds the largest market share of the global Fetal Monitors Market
North America is found to dominate the market as the United States and Canada have well-structured and developed healthcare systems. These countries are found to promote research and development for fetal monitors and hence, have very high expenditures on healthcare. As a result of these policies, many companies globally are encouraged to operate in this region.
Moreover, most of the population in developed countries like the United States are covered under medical and health insurance and can afford these care units. Hence, the North American region is expected to cover a large share of the neonatal intensive care market. As per the data published by the Centers for Medicare & Medicaid Services (CMS), in the United States, national healthcare spending is projected to grow at an average rate of 5.5% per year from 2018-to 2027, to reach nearly USD 6.0 trillion by 2027. Healthcare spending is projected to grow 0.8% faster than the GDP per year over 2018-2027. As a result, the healthcare share of GDP is expected to rise from 17.9% in 2017 to 19.4% by 2027. Additionally, according to the data from the National Center for Health Statistics, the percentage of preterm births in the United States increased from 9.57% in 2014 to 10.02% in 2018. The rise in preterm birth is expected to boost the demand for neonatal monitoring systems in the United States.
The fetal monitors market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Becton, Dickinson and Company, Fujifilm Holdings Corporation, Medtronic PLC, Draegerwerk AG & Co. KgaA, Huntleigh Healthcare Limited, CooperSurgical Inc., Koninklijke Philips NV, Natus Medical Incorporated, GE Healthcare, Siemens Healthineers among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the fetal monitors market globally. For instance, in June 2021, Nuvo Group received the United States Food and Drug Administration approval for the expanded utility of its INVU, which is a prescription-initiated remote pregnancy monitoring platform for the addition of a new uterine activity module that enables remote monitoring of uterine activity.
Koninklijke Philips NV
Koninklijke Philips NV is a Portabilitycompany, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and others.
SureSigns VM1: Philips Sure Signs VM1 is cost-effective, easy to use, and easy to support the patient monitor. Designed for adult, pediatric, and neonatal patients, it offers SpO₂, heart rate with options for CO₂, and key respiratory measurement parameters.
Why Purchase the Report?
Visualize the composition of the global fetal monitor’s market segmentation by product, portability, technique, and region highlighting the key commercial assets and players.
Identify commercial opportunities in the global fetal monitors market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of global fetal monitor’s market-level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the key product of all major market players
The global fetal monitor’s market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 180-200 (approximate) pages.
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
Global Fetal Monitors Market – By Product
Intrauterine Pressure Catheter
Electronic Fetal Monitoring
Accessories & Consumables
Global Fetal Monitors Market - By Portability
Global Fetal Monitors Market – By Technique
Global Fetal Monitors Market - By Region
Middle East & Africa
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook